Prothena lays off 63% of employees in fallout from phase 3 amyloidosis drug fail

Prothena is laying off almost two-thirds of its workforce as the Irish biotech navigates the fallout from giving up on its failed amyloidosis drug.

Jun 20, 2025 - 08:20
 0
Prothena lays off 63% of employees in fallout from phase 3 amyloidosis drug fail
Prothena is laying off almost two-thirds of its workforce as the Irish biotech navigates the fallout from giving up on its failed amyloidosis drug.